| Document and Entity Information | Aug. 05, 2020 |
| Cover [Abstract] | |
| Document Type | 8-K/A |
| Document Period End Date | Aug. 5, 2020 |
| Entity Registrant Name | DICERNA PHARMACEUTICALS, INC. |
| Entity Incorporation, State or Country Code | DE |
| Entity File Number | 001-36281 |
| Entity Tax Identification Number | 20-5993609 |
| Entity Address, Address Line One | 33 Hayden Avenue |
| Entity Address, City or Town | Lexington |
| Entity Address, State or Province | MA |
| Entity Address, Postal Zip Code | 02421 |
| City Area Code | 617 |
| Local Phone Number | 621-8097 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Common Stock, par value $0.0001 per share |
| Trading Symbol | DRNA |
| Security Exchange Name | NASDAQ |
| Entity Emerging Growth Company | false |
| Amendment Flag | false |
| Entity Central Index Key | 0001399529 |
